by Dr. Reinhard Hiller | Sep 22, 2014 | Blog, Emerging markets, Innovation management, The "Omics" Revolution
Yes! If a set of other components is in place to make a complex innovation equation work… Introduction Genomics holds great promises for drug development through the identification of new drug targets, better understanding of disease mechanism, and the elucidation of...
by Dr. Reinhard Hiller | Sep 19, 2014 | Blog, Emerging markets, The "Omics" Revolution
My short answer to this is, yes, but the real value of Genomics goes beyond an economic return and cannot be captured easily in dollars and cents! Background According to US-based non-profit research organisation Battelle, the Human Genome Project (HGP) contributed...
by Dr. Reinhard Hiller | Jul 15, 2014 | Blog, Emerging markets, Innovation management, R&D productivity
A recent paper in PLoS one [1] suggests that less than 1% of the globally active scientific community accounts for about 42% of all research output (measure = scientific publications; observation period = 1996-2011). If only high-impact papers are considered, a core...
by Dr. Reinhard Hiller | May 6, 2014 | Blog, Emerging markets, R&D productivity
A recent publication by Battelle provides a global overview and forecast of R&D spending as well as related challenges and drivers of success. What follows is a summary of key messages (text and figures), extracted from the Battelle report (2014 Global R&D...
by Dr. Reinhard Hiller | Sep 11, 2013 | Blog, Emerging markets
Overview While optimists have labelled the early 2000s as the dawn of the ‘Biomedical Century’ (1), a little more than 10 years into it many are bearish when thinking about the sector’s prospects. Among other factors, this viewpoint is guided by the declining R&D...
by Dr. Reinhard Hiller | Aug 14, 2013 | Blog, Emerging markets, Innovation management
In many countries, developed and emerging, research infrastructure (RI) is considered either an entitlement by the academic elite or an expense by those holding the purse strings. In my mind, it is neither! Rather, it is an investment made in service of a particular...
Recent Comments